SPAC12G12.07c Antibody

What is SPAC12G12.07c and why is it studied in research?

SPAC12G12.07c is a protein encoded by the fission yeast Schizosaccharomyces pombe (strain 972 / ATCC 24843). While specific research on this particular protein is limited in the provided search results, antibodies targeting this protein serve as important research tools for scientists investigating S. pombe cellular biology. The protein is identified by UniProt accession number Q09871 . Research involving S. pombe proteins like SPAC12G12.07c is valuable because this organism serves as an excellent model system for studying fundamental eukaryotic cellular processes, including cell division, DNA repair, and protein function. Methodologically, working with S. pombe allows researchers to extrapolate findings to more complex eukaryotic systems while benefiting from the relatively simple genetic structure of this organism.

What are the proper storage and handling conditions for SPAC12G12.07c antibody?

The SPAC12G12.07c antibody should be stored at -20°C or -80°C upon receipt. Repeated freeze-thaw cycles should be avoided to maintain antibody integrity and functionality . The antibody is provided in liquid form with a storage buffer containing 0.03% Proclin 300 (preservative), 50% Glycerol, and 0.01M PBS at pH 7.4 .

For optimal handling:

• Aliquot the antibody into smaller volumes upon receipt to minimize freeze-thaw cycles

• When removing from storage, thaw on ice

• Briefly centrifuge before opening to collect all liquid at the bottom of the tube

• Handle with appropriate laboratory safety measures (gloves, lab coat)

• Return to -20°C or -80°C immediately after use

While working with the antibody, maintain cold chain conditions whenever possible to preserve its binding capacity and specificity for experimental applications.

What applications has the SPAC12G12.07c antibody been validated for?

The SPAC12G12.07c antibody has been specifically tested and validated for the following applications:

• ELISA (Enzyme-Linked Immunosorbent Assay): For quantitative detection of the target protein in samples

• WB (Western Blot): For identification and semi-quantitative analysis of the target protein in cell or tissue lysates

When designing experiments, researchers should note that this antibody undergoes antigen affinity purification to ensure specificity for the target protein. The polyclonal nature of this antibody means it can recognize multiple epitopes on the target protein, potentially increasing sensitivity but requiring careful validation of specificity, particularly when exploring novel applications beyond those listed above.

How should I determine the optimal dilution for SPAC12G12.07c antibody in my experiments?

Determining the optimal dilution for the SPAC12G12.07c antibody requires systematic titration experiments specific to your application. While the product datasheet may provide recommended starting dilutions, these general guidelines should be refined for your specific experimental conditions.

Methodological approach:

• Start with a broad range of dilutions (e.g., 1:100, 1:500, 1:1000, 1:5000) in your specific application

• Run positive and negative controls alongside your samples

• Evaluate the signal-to-noise ratio at each dilution

• Select the dilution that provides the best combination of specific signal strength with minimal background

For Western blot applications, consider these additional factors:

• Protein loading amount

• Transfer efficiency

• Blocking conditions

• Secondary antibody selection and concentration

• Detection system sensitivity

For ELISA applications, also consider:

• Coating conditions

• Sample preparation method

• Incubation times and temperatures

• Washing stringency

Titration experiments should be repeated when changing any critical reagents or when working with new sample types to ensure optimal performance.

How can I validate the specificity of SPAC12G12.07c antibody in my experimental system?

Validating antibody specificity is crucial for ensuring reliable research outcomes. For SPAC12G12.07c antibody, a comprehensive validation strategy should include:

• Genetic Controls:

  • Use wild-type S. pombe cells alongside SPAC12G12.07c knockout or knockdown strains

  • If available, utilize strains with tagged versions of the target protein (e.g., His-tag, GFP)

• Peptide Competition Assay:

  • Pre-incubate the antibody with excess purified SPAC12G12.07c protein or immunogen peptide

  • A specific antibody will show reduced or eliminated signal in the presence of the competing antigen

• Mass Spectrometry Validation:

  • Immunoprecipitate using the SPAC12G12.07c antibody

  • Analyze precipitated proteins by mass spectrometry to confirm identity

• Cross-reactivity Assessment:

  • Test against related proteins or samples from different yeast species

  • Examine signals in organisms lacking SPAC12G12.07c homologs

• Multiple Detection Methods:

  • Compare results across different techniques (Western blot, immunofluorescence, ELISA)

  • Concordance between methods supports specificity

Similar validation approaches have been used for other antibodies in research. For instance, in studies of Covid-19 antibodies, researchers validated antibody specificity by examining reactivity across multiple viral proteins and correlating with functional outcomes .

What are the optimal protocols for using SPAC12G12.07c antibody in Western blot applications?

For optimal Western blot results with SPAC12G12.07c antibody, consider this methodological framework:

Sample Preparation:

• Extract proteins from S. pombe using either mechanical disruption (glass beads) or enzymatic methods (zymolyase treatment)

• Include protease inhibitors to prevent degradation

• Determine protein concentration (Bradford or BCA assay)

• Use 20-40 μg of total protein per lane

SDS-PAGE Conditions:

• Use 10-12% polyacrylamide gels for optimal separation

• Include molecular weight markers

• Run duplicate samples for positive and negative controls

Transfer Parameters:

• Use PVDF membrane (0.45 μm pore size) for optimal protein binding

• Transfer at 100V for 1 hour or 30V overnight at 4°C

• Verify transfer efficiency with reversible protein stain

Antibody Incubation:

• Block membrane with 5% non-fat milk or BSA in TBST for 1 hour at room temperature

• Incubate with SPAC12G12.07c antibody (start with 1:1000 dilution in blocking buffer)

• Incubate overnight at 4°C with gentle agitation

• Wash 3-5 times with TBST, 5 minutes each

• Incubate with appropriate secondary antibody (anti-rabbit IgG) conjugated to HRP or fluorescent tag

• Wash 3-5 times with TBST, 5 minutes each

Detection:

• Use enhanced chemiluminescence (ECL) substrate for HRP-conjugated antibodies

• Capture images using digital imaging systems

• For quantification, ensure signals are within linear range

Troubleshooting Tips:

• High background: Increase washing steps, dilute antibody further

• Weak signal: Decrease antibody dilution, increase protein loading, extend exposure time

• Multiple bands: Increase blocking time, check for protein degradation, verify sample preparation

Similar Western blot protocols have been successfully adapted for detecting various antibody targets, as demonstrated in studies of CD4bs antibodies to HIV .

How does SPAC12G12.07c antibody performance compare in different immunological techniques?

While the SPAC12G12.07c antibody has been specifically tested for ELISA and Western blot applications , researchers often explore additional techniques. Based on general principles of polyclonal antibody performance, here is a comparative analysis of expected performance across techniques:

When adapting this antibody to untested applications, researchers should:

• Include appropriate positive and negative controls

• Validate results with alternative methods

• Consider epitope accessibility in different sample preparation methods

• Document optimization parameters thoroughly

Studies of other antibodies have shown that performance can vary significantly between techniques due to differences in how epitopes are presented in each method .

What are the potential cross-reactivity concerns with SPAC12G12.07c antibody?

Understanding potential cross-reactivity is essential for accurate data interpretation. For SPAC12G12.07c antibody:

Potential Cross-Reactivity Sources:

• Closely Related Proteins Within S. pombe:

  • Proteins sharing structural or sequence homology

  • Splice variants or post-translationally modified forms of the target

• Proteins From Other Species:

  • While the antibody is raised against S. pombe SPAC12G12.07c, potential cross-reactivity with homologous proteins in other species should be considered

  • Cross-species application requires careful validation

Methodological Approaches to Assess and Mitigate Cross-Reactivity:

• Bioinformatic Analysis:

  • Perform BLAST searches to identify proteins with similar epitopes

  • Predict potential cross-reactive proteins based on sequence or structural similarities

• Experimental Validation:

  • Test the antibody against knockout/knockdown cells

  • Perform immunoprecipitation followed by mass spectrometry to identify all bound proteins

  • Compare detection patterns across different species or cell types

• Absorption Controls:

  • Pre-absorb the antibody with purified potential cross-reactive proteins

  • Monitor changes in detection patterns

• Specificity Enhancement:

  • Use more stringent washing conditions in your protocols

  • Consider affinity purification against the specific antigen

Similar approaches to evaluate antibody cross-reactivity have been employed in studies of various antibodies, including those targeting viral proteins in COVID-19 research .

How can I troubleshoot inconsistent results when using SPAC12G12.07c antibody?

Inconsistent results with antibodies can stem from multiple sources. Here's a structured approach to troubleshooting:

Systematic Troubleshooting Framework:

• Antibody Viability Issues:

  • Check storage conditions and freeze-thaw history

  • Verify antibody hasn't exceeded recommended shelf life

  • Test a new lot or aliquot of antibody

  Solution: Prepare fresh aliquots and store according to manufacturer recommendations (-20°C or -80°C)

• Sample Preparation Variables:

  • Inconsistent cell lysis or protein extraction efficiency

  • Protein degradation or modification during preparation

  • Batch-to-batch variation in cultures

  Solution: Standardize growth conditions and extraction protocols; include protease inhibitors

• Technical Execution:

  • Variation in incubation times or temperatures

  • Inconsistent washing procedures

  • Batch effects in reagents

  Solution: Use timers, temperature-controlled environments, and documented protocols

• Detection System Issues:

  • Substrate degradation or variability

  • Inconsistent exposure times

  • Equipment calibration drift

  Solution: Prepare fresh detection reagents; use calibrated equipment with consistent settings

Data Analysis Approach:

• Implement internal loading controls for normalization

• Run technical replicates to assess method reproducibility

• Include biological replicates to account for natural variation

• Use quantitative analysis software to reduce subjective interpretation

• Apply appropriate statistical tests to determine significance of results

Documentation Practices:

• Maintain detailed records of all experimental conditions

• Note lot numbers of all reagents used

• Document any deviations from standard protocols

• Record equipment settings and environmental conditions

Similar troubleshooting approaches have been successfully applied in antibody-based research for other targets, as demonstrated in studies of antibodies against internal viral proteins in COVID-19 .

How should I design experiments to study protein-protein interactions using SPAC12G12.07c antibody?

Designing robust experiments to investigate protein-protein interactions (PPIs) with SPAC12G12.07c antibody requires careful planning and appropriate controls:

Methodological Approaches:

• Co-Immunoprecipitation (Co-IP):

  • Use SPAC12G12.07c antibody to pull down the target protein and associated partners

  • Include appropriate controls:

    • IgG control (same species as SPAC12G12.07c antibody)

    • Lysate from cells lacking or depleted of SPAC12G12.07c

    • Competitive inhibition with immunizing peptide

  • Follow with Western blot or mass spectrometry to identify interaction partners

• Proximity Ligation Assay (PLA):

  • Combine SPAC12G12.07c antibody with antibodies against suspected interaction partners

  • Requires separate primary antibodies from different species

  • Fluorescent signal indicates proximity (<40 nm) between proteins

  • Include controls for antibody specificity and background signal

• Bimolecular Fluorescence Complementation (BiFC):

  • Genetic approach complementing co-IP studies

  • Engineer fusion constructs with split fluorescent protein fragments

  • Fluorescence occurs when fragments are brought together by interacting proteins

  • Compare with antibody-based detection for validation

Experimental Design Considerations:

• Physiological Relevance:

  • Consider native expression levels vs. overexpression

  • Evaluate interactions under different cellular conditions (stress, cell cycle stages)

  • Compare interactions in vitro vs. in vivo

• Temporal Dynamics:

  • Design time-course experiments to capture transient interactions

  • Consider synchronizing cells to study cell-cycle dependent interactions

• Structural Requirements:

  • Use domain deletion or mutation analysis to map interaction interfaces

  • Correlate with structural predictions or known domains

• Data Validation:

  • Confirm key interactions with multiple independent methods

  • Use quantitative approaches to assess interaction strength

  • Apply appropriate statistical analysis to distinguish specific from non-specific interactions

Similar experimental approaches have been successfully employed in studies of other protein interactions, including those involved in antibody recognition of viral proteins .

What considerations are important when analyzing post-translational modifications with SPAC12G12.07c antibody?

Analyzing post-translational modifications (PTMs) using SPAC12G12.07c antibody requires specialized approaches to ensure accurate detection and interpretation:

Key Methodological Considerations:

• Epitope Accessibility:

  • Determine if the antibody epitope includes or is affected by PTM sites

  • Verify if the antibody recognizes modified forms or only unmodified protein

  • Consider using complementary antibodies specific to the modified protein form

• Sample Preparation:

  • Include phosphatase inhibitors for phosphorylation studies

  • Add deubiquitinase inhibitors for ubiquitination analysis

  • Modify lysis buffers to preserve specific modifications

  • Consider enrichment strategies for low-abundance modified forms

• Separation Techniques:

  • Use Phos-tag™ acrylamide gels for phosphorylation studies

  • Apply 2D gel electrophoresis to separate protein isoforms

  • Consider using gradient gels for better separation of modified forms

• Detection Strategies:

  • Combine SPAC12G12.07c antibody with modification-specific antibodies

  • Use sequential probing or multiplexed detection systems

  • Consider mass spectrometry for precise PTM site identification

Validation Approaches:

• Treatment with modifying/demodifying enzymes:

  • Phosphatase treatment for phosphorylation studies

  • Deglycosylating enzymes for glycosylation analysis

• Genetic controls:

  • Mutate potential modification sites

  • Express constitutively modified or modification-resistant forms

• Pharmacological interventions:

  • Use inhibitors or activators of specific modifying enzymes

  • Monitor changes in modification patterns under different conditions

Data Interpretation Framework:

Similar approaches have been employed in research involving other antibodies to analyze post-translational modifications on target proteins .

How can I accurately quantify expression levels using SPAC12G12.07c antibody?

Accurate quantification of protein expression using SPAC12G12.07c antibody requires rigorous methodology and appropriate controls:

Quantitative Western Blot Protocol:

• Sample Preparation Standardization:

  • Harvest cells at consistent density and growth phase

  • Use standardized lysis protocols with protease inhibitors

  • Determine protein concentration using reliable methods (BCA or Bradford)

  • Prepare samples with equal protein loading (20-40 μg recommended)

• Electrophoresis and Transfer Optimization:

  • Use pre-cast gels for consistency between experiments

  • Include gradient reference samples for standard curve generation

  • Verify transfer efficiency with reversible staining (Ponceau S)

  • Consider stain-free technology for normalization to total protein

• Antibody Incubation Parameters:

  • Determine optimal antibody concentration through titration

  • Ensure detection is within linear range of response

  • Use fluorescently-labeled secondary antibodies for wider linear range

  • Include no-primary-antibody controls to assess background

• Signal Detection and Analysis:

  • Use digital imaging systems with appropriate exposure settings

  • Avoid saturated pixels that compromise linearity

  • Apply consistent analysis parameters between experiments

  • Use analysis software that can correct for background

Normalization Strategies:

• Loading Control Selection:

  • Traditional housekeeping proteins (GAPDH, β-actin, tubulin)

  • Total protein normalization (stain-free gels or total protein stains)

  • Spiked-in control proteins of known concentration

• Appropriate Control Samples:

  • Standard curve of purified protein if available

  • Reference sample included across all blots for inter-blot normalization

  • Positive and negative control samples (overexpression, knockout)

Statistical Considerations:

• Run at least three biological replicates

• Include technical replicates where feasible

• Apply appropriate statistical tests with consideration of data distribution

• Report both raw and normalized data for transparency

Similar quantitative approaches have been successfully employed in antibody-based research for other targets, including studies of antibody responses to viral proteins .

How can SPAC12G12.07c antibody be utilized in studying protein localization and trafficking?

The SPAC12G12.07c antibody can be a valuable tool for investigating protein localization and trafficking in S. pombe through several methodological approaches:

Immunofluorescence Microscopy Protocol:

Although not specifically validated for immunofluorescence , polyclonal antibodies often work in multiple applications. For immunofluorescence:

• Cell Preparation:

  • Fix S. pombe cells using either formaldehyde (protein crosslinking) or methanol (precipitation)

  • Digest cell wall with zymolyase or lysing enzymes to create spheroplasts

  • Permeabilize with detergent (0.1% Triton X-100) to allow antibody access

• Antibody Staining:

  • Block with BSA or normal serum to reduce non-specific binding

  • Incubate with SPAC12G12.07c antibody (start with 1:100-1:500 dilution)

  • Use fluorophore-conjugated anti-rabbit secondary antibody

  • Include DAPI for nuclear staining

• Controls and Validation:

  • Pre-immune serum control

  • Peptide competition to verify specificity

  • Comparison with GFP-tagged version of the protein

Subcellular Fractionation Approach:

• Fractionation Protocol:

  • Prepare cytoplasmic, nuclear, and membrane fractions

  • Verify fraction purity with marker proteins

  • Analyze SPAC12G12.07c distribution by Western blot

• Quantitative Analysis:

  • Measure relative abundance across fractions

  • Monitor changes under different conditions

  • Compare with live-cell imaging results

Dynamic Trafficking Studies:

• Inducible Systems:

  • Use temperature-sensitive mutants or chemical inhibitors

  • Track protein redistribution after stimulation

  • Combine with time-lapse microscopy of fluorescently tagged proteins

• Co-localization Analysis:

  • Dual immunostaining with organelle markers

  • Calculate Pearson's correlation coefficient

  • Use super-resolution microscopy for detailed localization

Similar approaches for studying protein localization have been applied in research involving other antibodies, including studies of viral protein distribution in infected cells .

What are the considerations for using SPAC12G12.07c antibody in chromatin immunoprecipitation (ChIP) experiments?

ChIP Protocol Adaptation:

• Crosslinking Optimization:

  • Test different formaldehyde concentrations (0.5-1.5%)

  • Optimize crosslinking time (5-20 minutes)

  • Consider dual crosslinking with additional agents for protein-protein fixation

• Chromatin Preparation:

  • Optimize sonication conditions for S. pombe cells

  • Verify fragment size distribution (200-500 bp ideal)

  • Pre-clear chromatin to reduce background

• Immunoprecipitation Parameters:

  • Determine optimal antibody amount through titration

  • Include IgG control and input samples

  • Consider pre-absorption with blocked protein A/G beads

• Washing and Elution:

  • Use progressively stringent washing buffers

  • Optimize elution conditions for maximum recovery

  • Reverse crosslinks completely before DNA purification

Validation Approaches:

• Control Regions:

  • Include known positive and negative genomic regions

  • Design primers spanning potential binding sites

  • Use spike-in controls for normalization

• Complementary Methods:

  • Compare with results from tagged versions of the protein

  • Validate key findings with electrophoretic mobility shift assay (EMSA)

  • Consider CUT&RUN or CUT&Tag as alternative approaches

• Data Analysis:

  • Apply appropriate normalization methods

  • Use peak calling algorithms suitable for your experimental design

  • Validate findings with biological replicates

Similar methodological considerations have been applied in ChIP experiments using other antibodies, particularly those targeting DNA-binding proteins or chromatin-associated factors .

How can I integrate SPAC12G12.07c antibody-based research with functional genomics approaches?

Integrating antibody-based research with functional genomics creates powerful synergies for comprehensive protein characterization:

Integrated Research Strategy:

• Correlation with Transcriptomics:

  • Compare protein abundance (Western blot) with mRNA levels (RNA-seq)

  • Investigate potential post-transcriptional regulation

  • Study protein expression under conditions where transcript levels change

• Proteomics Integration:

  • Use antibody for immunoprecipitation followed by mass spectrometry

  • Compare targeted antibody detection with global proteomics data

  • Identify post-translational modifications not detected by standard antibody methods

• Genetic Perturbation Analysis:

  • Create SPAC12G12.07c deletion, knockdown, or overexpression strains

  • Use the antibody to verify modification levels

  • Correlate molecular changes with phenotypic outcomes

• High-Content Screening:

  • Apply the antibody in immunofluorescence-based screens

  • Combine with genetic or chemical libraries

  • Identify conditions affecting protein localization or abundance

Data Integration Framework:

Bioinformatic Analysis:

• Use pathway enrichment analysis to contextualize findings

• Apply machine learning to integrate multiple data types

• Develop predictive models of protein function and regulation

• Compare findings across species using orthology mapping

Similar integrated approaches have been successfully employed in studies of other proteins, including research on antibody responses to viral proteins in COVID-19 and structural and functional analysis of HIV antibodies .